Highlighting American Cancer Society‐funded research in CA: A Cancer Journal for Clinicians

Since 1946, the American Cancer Society (ACS) has invested more to find the causes and cures of cancer than any other single nongovernmental, not-for-profit organization. Each year, the ACS extends this support to investigators at institutions across the United States as part of its grants program, funding research for high school interns through world-renowned professors, including the ACS Professorship. We applaud the grantees supported by the ACS; and, as part of this commitment to acknowledge and highlight these investigators, CA: A Cancer Journal for Clinicians (CA), is proud to launch a new series, "American Cancer Society Research Award Spotlight." As the flagship journal of the ACS, CA's goal is to educate and widely disseminate their work, and their passions, to our diverse audience of cancer professionals. Topics will be of relevance to the broad audience of CA, and much of the work will be developed in consultation between the authors and the editorial board. Notably, we have not restricted the scope of articles to research directly supported by the ACS. Rather, we will work with the authors on a topic that drives their career, whether in the laboratory or in the clinic, reflecting timely issues within the scope of oncology or society at large. In addition to recipients of our standard grant mechanisms, CA will feature content from recipients of the ACS Professor Award, which recognizes key thought leaders who have made substantial contributions in cancer research. For more information around ACS-funded cancer research, please visit https://www.cancer.org/research/currently-funded-cancer-research.html for a full list of up-to-date funded research grants and current and past ACS professors. Don S. Dizon reports personal/consulting fees from Doximity, ImmunoGen Inc, Puma Biotechnology Inc, Data and Safety Monitoring board for AstraZeneca, Clovis Oncology Inc., and GlaxoSmithKline LLC; and stock options in Midi outside the submitted work. Christina M. Annuniziata disclosed no conflicts of interest.